SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ViaCell (VIAC)
An SI Board Since January 2005
Posts SubjectMarks Bans Symbol
9 5 0 VIAC
Emcee:  Amy J Type:  Unmoderated
Introduction Market Data Compact
ViaCell is a stem cell research company, ticker symbol VIAC. VIAC recently IPO'ed on Nasdaq at $7, January 21, 2005.

They are dedicated to enabling the widespread application of human cells as medicine in the treatment of human disease.

The company is partially owned by AMGEN. ViaCell is also conducting stem cell research with Genzyme Corporation on diabetes. Scientists from various universities were involved in the creation of ViaCell.

ViaCell currently generates revenue thru cord blood used in bone marrow transplants. But they are looking towards future development in cellular medicine products with the first clinical trial of their product line, CB001, a highly concentrated and purified population of stem cells.

The CB001 was originally developed as a substitute for bone marrow and other hematopoietic stem cell transplants.
viacellinc.com
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9Here is my list of complaints. Too cheap Too few shares PerkinElmer should be Pkenhott-10/2/2007
8I had just finished the workup on viac after seeing bvf's 13g.keokalani'nui-10/1/2007
7Press Release Source: PerkinElmer, Inc. PerkinElmer to Expand Genetic Screeningkenhott-10/1/2007
6Children Can be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord keokalani'nui-9/27/2007
5ViaCell to be Added to NASDAQ Biotech Index biz.yahoo.com (Older news, but worAmy J-1/25/2006
4"good" for the general retail trading/investing community, since thereLawrence Burg-1/30/2005
3"Earlier this month, we took a look at this company and its ultra-clever buAmy J-1/25/2005
2Amgen Profits From Stem Cell IPO forbes.com Amgen (nasdaq: AMGN) bought 2.5 mAmy J-1/25/2005
1ViaCell shares surge after initial offering NEW YORK, Jan 21 (Reuters) - SharesAmy J-1/25/2005
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News